Binimetinib combined with Encorafenib advantages or disadvantages over BRAF-MEK inhibitor

Omid Hamid, MD Director of the Melanoma Center at The Angeles Clinic goes over the advantages and disadvantages with Binimetinib combined with Encorafenib